Zachary T. Bloomgarden
- CLINICAL PROFESSOR Medicine, Endocrinology, Diabetes and Bone Disease
American Board of Internal Medicine
MD, Albert Einstein College of Medicine
Residency, Internal Medicine
Montefiore Medical Center
Residency, Internal Medicine
Montefiore Medical Center
Vanderbilt University Hospital
Practice Address: 35 E 85th St , New York, NY, 10028-0954
Special Expertise: Diabetes; Diabetic Kidney Disease/Hypertension; Cholesterol/Lipid Disorders
Primary Care Physician: No
Foreign languages spoken in the office: Spanish ; French
Board Certification: Internal Medicine - 77; Endocrinology, Diabetes & Metabolism - 79
Dr. Bloomgarden has a national reputation for writing and lecturing on diabetes. He is active in the Division of Endocrinology & Metabolism of the Mount Sinai Medical Center, New York, NY, running a major teaching activity, the weekly diabetes clinic conferences, with the participation of speakers from the institution and numerous invited guests, as well as participating in teaching rounds in the Departments of Geriatrics and Pediatrics as well as Medicine.
He has worked in the American Diabetes Association as a member of the Editorial Board and, subsequently, serving as an Associate Editor of the clinical journal of, Diabetes Care, and has over the past four years written the monthly 'Perspectives on the News' column for this publication, a widely read and respected summary of current developments in the field, and has participated in other national activities. Additional writing includes reviews pertaining to the insulin resistance syndrome and to the treatment of type 2 diabetes, with Dr. Bloomgarden having contributed more than one hundred fifty publications in diabetes and related areas. Other activities which have gained him prominence include his membership on the Editorial Board, Practical Diabetology, his serving as a Founding Member of the Metropolitan Diabetes Society of New York, his participating in the Committee on the Relationship of Socioeconomic Status to Cardiovascular Mortality, American Heart Association, and his activity as a reviewer for the Archives of Internal Medicine, the Journal of Clinical Endocrinology and Metabolism, and Diabetes Care. He serves on the Publications Committee of the American Association of Clinical Endocrinology.
Dr. Bloomgarden has acted as an advisor for a number of pharmaceutical groups, including the Diabetes Medical Advisory Board, Merck-Medco Managed Care, the Amaryl Advisory Panel, Hoechst Marion Roussel, the Novartis Lipid and Diabetes Advisory Boards, the National Diabetes Education Initiative faculty, the Vascular Biology Working Group, the Novo Nordisk Diabetes Management Pharmacological Therapy faculty, and the Bristol Meyers Squibb Diabetes Education Faculty. In addition to numerous lectures given locally, he has been invited to speak in a variety of institutions around the country as well as giving many lectures internationally, including talks in South Africa, in Poland, in China at the annual meeting of the Chinese Diabetes Association, and in Brazil where he became an honorary professor at the Biocor Hospital de Doen? Cardiovasculares.
He has been a principal investigator in numerous clinical studies, assessing treatment with troglitazone, glyburide, insulin, metformin, glimepiride, glipizide, fluvastatin, of dichloroacetate in the treatment of lactic acidosis, of patient education in diabetes, and of the role of sildenafil in the treatment of erectile dysfunction in males with diabetes.
In his successful clinical practice, Dr. Bloomgarden is one of the best well-known diabetologists in New York. He has been listed for several years in the publication, 'Castle Connolly Guide: The Best Doctors New York Metro Area,' in this field, and serves as a consultant for a number of local medical groups and for the Lawrence Hospital in Bronxville.
Bloomgarden ZT. Diet and Diabetes. Diabetes Care 2004 Nov; 27(11): 2755-60.
Bloomgarden ZT. Gut-Derived Incretin Hormones and New Therapeutic Approaches. Diabetes Care 2004 Oct; 27(10): 2554-9.
Bloomgarden ZT. Inpatient Diabetes Control: Approaches to treatment. Diabetes Care 2004 Sep; 27(9): 2272-7.
Bloomgarden ZT. Inpatient Diabetes Control: Rationale. Diabetes Care 2004 Aug; 27(8): 2074-80.
Bloomgarden ZT. Dyslipidemia and the Metabolic Syndrome. Diabetes Care 2004 Dec; 27(12): 3009-16.
Bloomgarden ZT. Diabetic Retinopathy and Neuropathy . Diabetes Care 2005 Apr; 28(4): 963-70.
Bloomgarden ZT. Diabetic Nephropathy . Diabetes Care 2005 Mar; 28(3): 745-51.
Bloomgarden ZT. Thiazolidinediones. Diabetes Care 2005 Feb; 28(2): 488-93.
Bloomgarden ZT. Transplantation and Islet Topics. Diabetes Care 2005 Jan; 28(1): 213-9.
Bloomgarden ZT. The European Association for the Study of Diabetes. Diabetes Care 2005 May; 28(5): 1250-7.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Bloomgarden is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
35 East 85th Street
New York, NY 10028
- Monday 9:30am - 4:00pm
- Tuesday 9:30am - 4:00pm
- Wednesday 9:30am - 7:00pm
- Thursday 10:30am - 5:00pm
- Friday 9:30am - 4:00pm
- 1199 National Benefit Fund
- Medicare Assignment
- Private Healthcare Systems (PHCS)
- Personal Check